Trials / Enrolling By Invitation
Enrolling By InvitationNCT05282706
Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting
A Placebo-controlled Clinical Trial Investigating the Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting
- Status
- Enrolling By Invitation
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Use of inhaled essential oils to reduce the symptoms of pain or nausea, enabling a patient to have increase participation with PT or OT, thereby minimizing hospitalization-related risks and potentially reducing the length of stay in the hospital.
Detailed description
The study intervention consists of 3 essential oils: lavender, mandarin and peppermint administered on an inhalation patch affixed in the chest region of the participant gown. The inhalation patch consists of hydrogel cast onto polyester film, supported by non-woven polyester fabric, covered with a polyethylene film. The proprietary foil-backed lamination on the patch is used to provide an occlusive barrier that prevents any essential oil from being absorbed through the skin. The placebo will consist of a comparable sized felt patch with adhesive backing with no essential oil applied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lavender Oil | A hydrogel lavender oil infused aromatherapy patch |
| DRUG | Mandarin Oil | A hydrogel mandarin oil infused aromatherapy patch |
| DRUG | Peppermint oil | A hydrogel peppermint oil infused aromatherapy patch |
| OTHER | Placebo | A placebo patch containing no aromatherapy oil |
Timeline
- Start date
- 2022-05-16
- Primary completion
- 2026-05-01
- Completion
- 2026-12-01
- First posted
- 2022-03-16
- Last updated
- 2025-06-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05282706. Inclusion in this directory is not an endorsement.